JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1326
PUT
MetLife
MET
$62.7B
| $50.2M | ﹤0.01% |
612,600
+195,000
| +47% | +$16.2M |
2021 Q2
14 quarters
|
|
1327
Columbia Banking Systems
COLB
$8.21B
| $50M | ﹤0.01% |
1,851,217
+1,134,544
| +158% | +$32.5M |
2013 Q2
46 quarters
|
|
1328
Cognex
CGNX
$11B
| $49.9M | ﹤0.01% |
1,391,851
-392,388
| -22% | -$15.4M |
2015 Q4
36 quarters
|
|
1329
PUT
Home Depot
HD
$285B
| $49.9M | ﹤0.01% |
128,300
| – | – |
2017 Q2
30 quarters
|
|
1330
Douglas Emmett
DEI
$1.65B
| $49.8M | ﹤0.01% |
2,684,597
+1,520,348
| +131% | +$28.3M |
2013 Q2
46 quarters
|
|
1331
Independence Realty Trust
IRT
$3.51B
| $49.7M | ﹤0.01% |
2,506,902
+11,784
| +0.5% | +$241K |
2016 Q1
35 quarters
|
|
|
TMHC
1332
DELISTED
Taylor Morrison
TMHC
| $49.7M | ﹤0.01% |
811,253
+156,793
| +24% | +$10.7M |
2016 Q4
32 quarters
|
|
1333
Procept Biorobotics
PRCT
$1B
| $49.5M | ﹤0.01% |
615,166
-197,200
| -24% | -$16.8M |
2021 Q4
12 quarters
|
|
1334
Lemonade
LMND
$3.6B
| $49.5M | ﹤0.01% |
1,349,356
+1,299,891
| +2,628% | +$41.5M |
2020 Q3
17 quarters
|
|
1335
Carlyle Group
CG
$14.1B
| $49.5M | ﹤0.01% |
979,411
-940,028
| -49% | -$47.6M |
2013 Q2
46 quarters
|
|
1336
CALL
Kinder Morgan
KMI
$71.2B
| $49.4M | ﹤0.01% |
1,801,500
+29,300
| +2% | +$764K |
2014 Q3
41 quarters
|
|
1337
Itron
ITRI
$3.86B
| $49.2M | ﹤0.01% |
452,939
-179,046
| -28% | -$20M |
2013 Q2
46 quarters
|
|
1338
Abercrombie & Fitch
ANF
$6.08B
| $49M | ﹤0.01% |
327,942
-7,945
| -2% | -$1.16M |
2013 Q2
46 quarters
|
|
1339
iShares Global Healthcare ETF
IXJ
$4.29B
| $49M | ﹤0.01% |
569,525
-54,144
| -9% | -$5M |
2014 Q4
40 quarters
|
|
1340
ASE Group
ASX
$122B
| $49M | ﹤0.01% |
4,861,813
+1,290,605
| +36% | +$12.9M |
2013 Q2
46 quarters
|
|
1341
Medpace
MEDP
$17.1B
| $48.9M | ﹤0.01% |
147,166
-28,073
| -16% | -$9.52M |
2017 Q3
29 quarters
|
|
1342
Vanguard Total World Stock ETF
VT
$82.2B
| $48.7M | ﹤0.01% |
414,572
-46,314
| -10% | -$5.56M |
2013 Q4
44 quarters
|
|
1343
CALL
Merck
MRK
$350B
| $48.5M | ﹤0.01% |
487,200
+228,800
| +89% | +$23.6M |
2014 Q3
41 quarters
|
|
1344
Stride
LRN
$3.3B
| $48.3M | ﹤0.01% |
465,210
+237,310
| +104% | +$22.6M |
2014 Q2
42 quarters
|
|
1345
Meritage Homes
MTH
$4.13B
| $48.3M | ﹤0.01% |
628,646
+156,174
| +33% | +$14.2M |
2015 Q4
36 quarters
|
|
1346
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.5B
| $48.3M | ﹤0.01% |
533,985
+339
| +0.1% | +$31.2K |
2013 Q2
46 quarters
|
|
1347
BP
BP
$116B
| $48M | ﹤0.01% |
1,622,821
-603,416
| -27% | -$18.1M |
2013 Q2
46 quarters
|
|
1348
Ollie's Bargain Outlet
OLLI
$5.13B
| $47.9M | ﹤0.01% |
436,366
+247,065
| +131% | +$24.6M |
2015 Q3
37 quarters
|
|
1349
iShares Core MSCI Total International Stock ETF
IXUS
$59.6B
| $47.8M | ﹤0.01% |
723,464
-373,586
| -34% | -$25.9M |
2016 Q2
34 quarters
|
|
1350
Invesco Preferred ETF
PGX
$3.62B
| $47.8M | ﹤0.01% |
4,148,592
+2,359,356
| +132% | +$28.4M |
2014 Q4
40 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.